Detalhe da pesquisa
1.
Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosis.
Br J Haematol
; 193(3): 674-677, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713427
2.
Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment.
Leuk Lymphoma
; 62(4): 979-983, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33251891